Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 26 X posts from 17 X users, with an upper bound of 77,110 followers.

RT @TaeWoongUSA: Dr. Nirav Thosani, MD, MHA @iGUT_Houston has released a new study on endoscopic ultrasound radiofrequency ablation for pan…

RT @TaeWoongUSA: Dr. Nirav Thosani, MD, MHA @iGUT_Houston has released a new study on endoscopic ultrasound radiofrequency ablation for pan…

Dr. Nirav Thosani, MD, MHA @iGUT_Houston has released a new study on endoscopic ultrasound radiofrequency ablation for pancreatic ductal adenocarcinoma. Read the full article here: https://t.co/ewS4mQ2SwL #EUS #RFA #pancreaticcancer #adenocarcinoma #gas

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 22 additional X posts.